ASSOCIATION OF HLA POLYMORPHISMS WITH EPSTEIN-BARR VIRUS INFECTION AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0
|
作者：
Lin, R. [1 ]
Fan, Q. [1 ]
Yu, S. [1 ]
Fan, Z. [1 ]
Zhang, Y. [1 ]
Huang, F. [1 ]
Zhou, H. [1 ]
Xuan, L. [1 ]
Wu, M.
Guo, X. [1 ]
Dai, M. [1 ]
Sun, J. [1 ]
Liu, Q. [1 ]
机构：
[1] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P894
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [31] EPSTEIN-BARR VIRUS ASSOCIATED CENTRAL NERVOUS SYSTEM DISEASES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Liu, Q.
    Wu, M. Q.
    Huang, F.
    Fan, Z.
    Zhou, H. S.
    Zhang, X.
    Yu, G.
    Sun, J.
    HAEMATOLOGICA, 2012, 97 : 411 - 411
  • [32] Features of Epstein-Barr virus reactivation after reduced-intensity conditioning allogeneic stem cell transplantation
    Peric, Z.
    Chevallier, P.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Dubruille, V.
    Le Gouill, S.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Saulquin, B.
    Milpied, N.
    Vrhovac, R.
    Harousseau, J. L.
    Moreau, P.
    Coste-Burel, M.
    Imbert-Marcille, B. M.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S287 - S287
  • [33] MOLECULAR MONITORING AND STEPWISE PREEMPTIVE THERAPY FOR EPSTEIN-BARR VIRUS VIREMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Liu, Q.
    Xuan, L.
    Liu, H.
    Huang, F.
    Zhou, H.
    Fan, Z.
    Zhao, K.
    Wu, M.
    Xu, L.
    Zhai, X.
    Zhang, F.
    Liu, C.
    Sun, J.
    Huang, X.
    HAEMATOLOGICA, 2013, 98 : 157 - 157
  • [34] Incidence and Impact of Epstein-barr Virus Events in the Early Phase after Allogeneic Hematopoietic Stem Cell Transplantation
    Macy, Samuel
    Khanna, Nina
    Hirsch, Hans
    Heim, Dominik
    Lengerke, Claudia
    Tsakiris, Dimitrios
    Passweg, Jakob
    Medinger, Michael
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 485 - 485
  • [35] Increased Infection Rate After Preemptive Rituximab Treatment for Epstein-Barr Virus Reactivation After Allogeneic Hematopoietic Stem-Cell Transplantation
    Petropoulou, Anna D.
    Porcher, Raphael
    de Latour, Regis Peffault
    Xhaard, Alienor
    Weisdorf, Daniel
    Ribaud, Patricia
    Rodriguez-Otero, Paula
    Agbalika, Felix
    Talbot, Alexis
    Toubert, Antoine
    Moins-Teisserenc, Helene
    Carmagnat, Maryvonnick
    Socie, Gerard
    Robin, Marie
    TRANSPLANTATION, 2012, 94 (08) : 879 - 883
  • [36] Epstein-Barr virus reactivation after allogeneic hematopoietic stem cell transplantation: multifactorial impact on transplant outcomes
    Ru, Yuhua
    Zhang, Xiang
    Song, Tiemei
    Ding, Yiyang
    Zhu, Ziling
    Fan, Yi
    Xu, Yang
    Sun, Aining
    Qiu, Huiying
    Jin, Zhengming
    Tang, Xiaowen
    Han, Yue
    Fu, Zhengzheng
    Chen, Suning
    Ma, Xiao
    Chen, Feng
    Chen, Jia
    Wu, Depei
    BONE MARROW TRANSPLANTATION, 2020, 55 (09) : 1754 - 1762
  • [37] Molecular monitoring and stepwise preemptive therapy for Epstein-Barr virus viremia after allogeneic stem cell transplantation
    Liu, Qifa
    Xuan, Li
    Liu, Hui
    Huang, Fen
    Zhou, Hongsheng
    Fan, Zhiping
    Zhao, Ke
    Wu, Meiqing
    Xu, Lanping
    Zhai, Xiao
    Zhang, Fuhua
    Liu, Can
    Sun, Jing
    Huang, Xiaojun
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (07) : 550 - 555
  • [38] Clinical characteristics and outcomes of Epstein-Barr virus viral load after allogeneic hematopoietic stem cell transplantation
    Tsushima, Takafumi
    Masuda, Shin-Ichi
    Yoda, Natsumi
    Kainuma, Sayaka
    Kimeda, Chiharu
    Konno, Shiho
    Tanaka, Kazusuke
    Matsuo, Kosuke
    Shimoji, Sonoko
    Kimura, Kenji
    Arai, Hironori
    Utsu, Yoshikazu
    Imadome, Ken-Ichi
    Aotsuka, Nobuyuki
    ANNALS OF HEMATOLOGY, 2024, 103 (03) : 935 - 946
  • [39] Clinical characteristics and outcomes of Epstein-Barr virus viral load after allogeneic hematopoietic stem cell transplantation
    Takafumi Tsushima
    Shin-Ichi Masuda
    Natsumi Yoda
    Sayaka Kainuma
    Chiharu Kimeda
    Shiho Konno
    Kazusuke Tanaka
    Kosuke Matsuo
    Sonoko Shimoji
    Kenji Kimura
    Hironori Arai
    Yoshikazu Utsu
    Ken-Ichi Imadome
    Nobuyuki Aotsuka
    Annals of Hematology, 2024, 103 : 935 - 946
  • [40] The presence of IFNG 3/3 genotype in the recipient associates with increased risk for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation
    Bogunia-Kubik, K
    Mlynarczewska, AS
    Jaskula, E
    Lange, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 132 (03) : 326 - 332
12345